My Newsfeed

logo
The Baseline
27 May 2025
Five stocks to buy from analysts this week - May 27, 2025
By Divyansh Pokharna

1. Arvind Fashions:

Anand Rathi maintains a ‘Buy’ rating on this apparel company with a target price of Rs 681, indicating an upside of 50.6%. The company's share price has taken a hit recently, declining by 20.7% over the past six months. Arvind Fashions markets and distributes branded apparel and accessories, and reported a net loss of Rs 93.2 crore in Q4FY25, against a profit of Rs 24.3 crore in Q4FY24. The loss was mainly due to a one-time deferred tax charge of Rs 1,200 crore, following a shift in its subsidiary Arvind Lifestyle Brands’ tax rate from 35% to 25%.

Looking past that figure, all five core brands (US Polo, Tommy Hilfiger, etc.) posted double-digit revenue growth in Q4, with most also delivering double-digit EBITDA growth. For the full year, the company reported 8.5% revenue growth and a 100 bps improvement in its EBITDA margin. This performance was supported by premiumization and a shift toward stronger, well-established brands.

Analyst Vaishnavi Mandhaniya finds initial FY26 trends encouraging, noting improved comparable growth (same-store sales) in the first 45 days. She expects supportive macro conditions and tax cuts to drive growth above 5% in FY26 (5.5% in FY25).

The company’s management maintains its guidance of 12-15% revenue growth in FY26, supported by a recovery in the wholesale channel and steady growth in the retail channel.

2. Karur Vysya Bank:

Emkay reiterates its ‘Buy’ rating on this bank with a target price of Rs 300, a 32.3% upside. In Q4FY25, the bank’s gross NPA ratio improved by 64 bps YoY to 0.8%, supported by lower slippages, higher write-offs, and better recoveries. Net NPAs stood at 0.2%. Analysts Anand Dama, Nikhil Vaishnav, and Kunaal N note this is among the lowest NPAs in its peer group, including City Union, Ujjivan, and Equitas SFB. The bank features in a screener of stocks with good Trendlyne valuation scores.

The management expects gross NPAs to stay below 1% and net NPAs of around 0.5% in FY26, with slippages likely to remain under 1%. Net interest margin (NIM) was broadly stable at 4.1% due to a shift toward higher-yielding, secured retail loans. However, the bank expects margins to moderate to 3.7–3.75%, in line with possible policy rate cuts.

For FY25, the bank’s net profit rose 21% to Rs 1,942 crore, while revenue grew 16.7% driven by higher interest income and investment earnings. Dama and team expect the bank to deliver a return on equity (RoE) of 16–18%, supported by strong asset quality, healthy capital and provision buffers, and stable management.

3. Bharat Electronics:

ICICI Securities maintains its ‘Buy’ rating on this defence company and raises the target price to Rs 420, indicating an upside of 8.9%. In Q4FY25, the company’s revenue grew 6.8% YoY to Rs 9,149 crore and net profit rose 18.4% to Rs 2,127 crore, helped by high-margin orders and improved execution.

For FY25, revenue grew 15% and net profit rose 33.4%, driven by an increase in new orders. The company's management expects an order inflow of over Rs 57,000 crore over the next 12–13 months, driven by emergency procurement orders from the Ministry of Defence and export demand.

Analysts Amit Dixit and Mohit Lohia remain optimistic about Bharat Electronics’ software-defined radios (SDRs) segment for naval programmes. They expect BEL to secure 85% of the upcoming SDR orders from the Indian Navy, with a potential order book of Rs 8,000–10,000 crore.

BEL targets a 15% revenue CAGR and 20% profit CAGR over the next 3–4 years. Analysts also remain positive about the company’s growth prospects beyond defence. They expect order book execution to remain strong, backed by healthy margins over the next 2–3 years. 

4. Transport Corp of India:

Sharekhan maintains a ‘Buy’ rating on this logistics solutions player with a target price of Rs 1,350, implying a 18% upside. In FY25, the company’s revenue rose 11.6% YoY to Rs 4,491.8 crore, led by the supply chain management (SCM) segment. Growth in SCM was supported by new contracts and expansion in the warehousing, quick commerce, and automotive sectors. Its net profit increased by 16.8% during the year.

Transport Corporation’s management expects 10–12% growth in revenue and profit for FY26. The SCM segment is projected to grow 12–15% and remain the key revenue driver. Analysts note the company’s plans to invest Rs 400–450 crore in FY26 to expand infrastructure, including ships, trucks, and warehouses.

Analysts believe the company is well-positioned to benefit from the Centre’s AtmaNirbhar Bharat push and global supply chain shifts. They estimate revenue and net profit to grow by 12.4% and 15.4%, respectively, over FY26–27.

5. Sun Pharmaceuticals:

Motilal Oswal maintains a ‘Buy’ rating on this pharma company with a target price of Rs 2,000, an upside of 18.8%. In Q4FY25, the company’s revenue grew 8.2% YoY to Rs 12,958 crore but missed estimates by 4% due to lower-than-expected sales in global specialty drugs and rest of the world (ROW) markets. Net profit also missed estimates by 4% due to higher litigation expenses and restructuring of US operations.

During the quarter, the company launched 10 new products across multiple therapy areas, such as pain management and anti-diabetics. These launches are expected to drive an 11% sales CAGR in the DF segment by FY27. Analyst Tushar Manudhane expects Sun Pharma to outperform the industry in India’s domestic formulation (DF) market due to new product launches and strong growth in existing brands.

For FY25, the company's revenue grew 9.4% and net profit rose 14.4%. The management aims to achieve mid-to-high single-digit revenue growth in FY26, supported by new specialty product launches in 2025.

The company plans to invest Rs 830 crore in FY26 towards promotional activities and research and development (R&D) expansion for its specialty portfolio. The analysts project the company’s net profit to grow at a CAGR of 17% over FY26–27.

Note: These recommendations are from various analysts and are not recommendations by Trendlyne.

(You can find all analyst picks here)

Trendlyne Marketwatch
Trendlyne Marketwatch
27 May 2025
Market closes lower, Bondada Engineering bags a Rs 204 crore order in Telangana
By Trendlyne Analysis

Nifty 50 closed at 24,826.20 (-175.0, -0.7%) , BSE Sensex closed at 81,551.63 (-624.8, -0.8%) while the broader Nifty 500 closed at 22,816.50 (-91.8, -0.4%). Market breadth is horizontal. Of the 2,431 stocks traded today, 1,162 were on the uptrend, and 1,224 went down.

Indian indices closed lower after extending losses in the afternoon session. The Indian volatility index, Nifty VIX, rose 2.9% and closed at 18.5 points. InterGlobe Aviation closed in the red as Co-founder Rakesh Gangwal reportedly sold 2.3 crore shares (5.8% stake) worth Rs 11,928 crore in a block deal at a floor price of Rs 5,260 per share.

Nifty Smallcap 100 and Nifty Midcap 100 closed flat. Nifty India Defence and S&P BSE Telecom were among the best-performing indices of the day. According to Trendlyne’s sector dashboard, Healthcare Equipment & Supplies emerged as the worst-performing sector of the day, with a fall of 2.3%.

European indices are trading in the green, except Portugal’s PSI index, which is trading 0.5% lower. Major Asian indices closed mixed. US index futures are trading higher, indicating a positive start to the session, after President Donald Trump agreed to postpone import tariffs on goods from the European Union.

  • Relative strength index (RSI) indicates that stocks like Pfizer, Bharat Electronics, Emcure Pharmaceuticals, and Max Financial Services are in the overbought zone.

  • Chennai Petroleum Corp secures approval from the Ministry of Petroleum & Natural Gas to sell motor spirit and high speed diesel through its own retail outlets.

  • Godawari Power & Ispat receives approval from the Indian Bureau of Mines, Gov. of India to resume operations at the Boria Tibu mines for the next five years.

  • Bondada Engineering rises sharply as it secures a Rs 204.2 crore order from Telangana Power Generation Corp. The project involves setting up a 100 megawatt-hour (MWh) battery energy storage system under the build-own-operate (BOO) model. It is scheduled for completion within 18 months from execution of the power purchase agreement.

  • Fusion CX, a customer experience service provider, files draft papers with SEBI to raise up to Rs 1,000 crore through an IPO. The offer includes a fresh issue of Rs 600 crore and an offer-for-sale (OFS) worth Rs 400 crore.

  • Lumax Industries' Q4FY25 net profit rises 21.9% YoY to Rs 44 crore. Revenue increases 24.3% YoY to Rs 923.4 crore, driven by higher sales to customers such as Mahindra & Mahindra, Honda Motorcycle & Scooter India, and Hero MotoCorp during the quarter. The company appears in a screener of stocks outperforming their industry price change in the quarter.

  • Aditya Birla Fashion and Retail rises as it plans a Rs 500 crore capex in FY26, aiming to make loss-making units TCNS Clothing, Tasva, and TMRW profitable by FY26. The company's net loss narrows to Rs 16.9 crore in Q4FY25 from Rs 229.6 crore a year ago, aided by inventory destocking.

  • PTC Industries' Q4FY25 net profit surges 3.8x YoY to Rs 343.4 crore, helped by lower purchases, employee benefits, and finance costs and exceptional gains of Rs 306 crore from the sale of its subsidiary, PTC Energy. However, revenue declines 13.7% YoY to Rs 3,030.5 crore due to reductions in the power and financing business segments. It appears in a screener of stocks with above-line growth and below-line valuations.

  • SEBI approves the registration of Jio BlackRock Mutual Fund, a joint venture between Jio Financial Services and BlackRock Financial Management. Both companies will serve as co-sponsors and establish the proposed mutual fund.

  • Sumitomo Chemical India is falling as its net profit drops 9.2% YoY to Rs 99.6 crore in Q4FY25 due to higher employee benefit expenses and material costs. However, revenue increases 0.8% YoY to Rs 679.4 crore during the quarter. The company appears in a screener of stocks with declining ROE over the past two years.

  • General Insurance Corp of India falls as its Q4FY25 net profit declines 3.2% YoY to Rs 2,498.9 crore, weighed down by higher commissions, operating expenses, and claims paid. However, revenue increases 28.8% YoY to Rs 11,942.5 crore, driven by improvements in premiums from the fire, motor, engineering, personal accident, and health insurance segments. It features in a screener of stocks with an increasing trend in non-core income.

  • Borana Weaves' shares debut on the bourses at a 12.5% premium to the issue price of Rs 216. The Rs 144.9 crore IPO received bids for 148.8 times the total shares on offer.

  • Parakram Jadeja, CMD of Jyoti CNC Automation, projects over 35–40% revenue growth for FY26, with margins in the 25–27% range. He also expects working capital to improve to 160–170 days. Jadeja adds that the company has received enquiries from Germany, France, and Italy for its aerospace and defence offerings.

  • Akums Drugs is rising as it reports a Q4FY25 net profit of Rs 147.6 crore compared to a net loss of Rs 41.3 crore in Q4FY24, helped by lower inventory and finance costs and tax returns of Rs 74.5 crore. Revenue grows 12.4% YoY to Rs 1,073.1 crore, driven by improvements in the contract development & manufacturing organization (CDMO) and branded formulations segments. It features in a screener of stocks with YoY growth in operating profit and margins.

  • Goldman Sachs initiates coverage on Varun Beverages with a 'Buy' rating and a target price of Rs 600. The brokerage expects the company to generate free cash flow following its spending on facility expansion. It believes Varun’s South Africa business EBITDA margins will improve from 10% to 17% during CY25-27, driven by rising volumes.

  • Sagility falls as its promoter plans to sell up to a 15% stake through an offer for sale (OFS) at Rs 38 per share. The OFS opens for non-retail investors on May 27 and retail investors on May 28.

  • Brainbees Solutions declines over 5% as the Bureau of Indian Standards (BIS) initiates search and seizure operations at its warehouses in Bengaluru. BIS has reportedly seized certain goods worth approx Rs 90 lakh. The operation is a part of BIS's efforts to curb the distribution of non-compliant products through e-commerce platforms, targeting items lacking the mandatory BIS certification.

  • InterGlobe Aviation falls as Co-founder Rakesh Gangwal reportedly sells 2.3 crore shares (5.8% stake) worth Rs 11,928 crore in a block deal at a floor price of Rs 5,260 per share.

  • Olectra Greentech is falling as Maharashtra Transport Minister Pratap Sarnaik directs officials to cancel the Rs 10,000 crore e-bus order awarded to the company for failing to meet delivery timelines. The order involved the supply of 5,150 electric buses.

  • Reports suggest that PG Electroplast promoters may sell 1.5 crore shares (5.6% stake) worth Rs 1,177 crore in a block deal on Tuesday at an average price of Rs 740 per share.

  • RateGain Travel Technologies falls over 8% after issuing weaker-than-expected FY26 guidance. The company projects revenue growth of 6–8% YoY, a sharp slowdown from the 12.5% growth in FY25. It also guides for 15–17% EBITDA margins, down from 21.6% in FY25, citing aggressive go-to-market investments, particularly in the APAC (Asia-Pacific) and Middle East regions.

  • Orchid Pharma is falling as its net profit declines 32.4% YoY to Rs 22.3 crore in Q4FY25 due to lower inventory destocking and higher stock-in-trade purchases. However, revenue increases 9.4% YoY to Rs 237.5 crore during the quarter. The company appears in a screener of stocks where mutual funds increased their shareholding in the past quarter.

  • Aurobindo Pharma is rising as its Q4FY25 revenue grows 10.4% YoY to Rs 8,516.9 crore, driven by improvements in the US & Europe formulations, growth markets, antiretroviral (ARV), and active pharmaceutical ingredients (API) segments. However, net profit declines 0.6% YoY to Rs 903.5 crore due to higher raw materials, employee benefits, finance, and depreciation & amortisation expense. It appears in a screener of stocks with decreasing promoter pledges.

  • Bayer Cropscience rises sharply as its net profit surges 49.3% YoY to Rs 143.3 crore in Q4FY25, helped by inventory destocking. Revenue increases 32.2% YoY to Rs 1,046.4 crore, driven by an improvement in the spring corn and crop protection portfolio during the quarter. The company appears in a screener of stocks underperforming their industry price change in the quarter.

  • KEC International rises sharply as its Q4FY25 net profit surges 76.7% YoY to Rs 268.2 crore, led by lower inventory and erection & subcontracting expenses. Revenue jumps 11.7% YoY to Rs 6,892.3 crore, driven by an improvement in the engineering, procurement & construction segment. It features in a screener of stocks with annual net profit growth higher than sector profit growth.

  • Nifty 50 was trading at 24,874.30 (-126.9, -0.5%), BSE Sensex was trading at 82,038.20 (-138.3, -0.2%) while the broader Nifty 500 was trading at 22,850.75 (-57.6, -0.3%).

  • Market breadth is in the green. Of the 1,986 stocks traded today, 1,043 were on the uptick, and 888 were down.

Riding High:

Largecap and midcap gainers today include GlaxoSmithKline Pharmaceuticals Ltd. (3,118.20, 5.3%), Supreme Industries Ltd. (4,200.40, 4.1%) and Container Corporation of India Ltd. (768.70, 3.5%).

Downers:

Largecap and midcap losers today include General Insurance Corporation of India (416.40, -3.5%), UltraTech Cement Ltd. (11,421, -2.3%) and ITC Ltd. (433.90, -2.0%).

Movers and Shakers

23 stocks in BSE 500 are trading on high volumes today.

Top high volume gainers on BSE included Bayer Cropscience Ltd. (5,674, 10.6%), ITI Ltd. (309.25, 10.0%) and Minda Corporation Ltd. (550.55, 5.2%).

Top high volume losers on BSE were Olectra Greentech Ltd. (1,257.90, -6.5%), Sumitomo Chemical India Ltd. (503.20, -5.8%) and TTK Prestige Ltd. (645.90, -5.8%).

InterGlobe Aviation Ltd. (5,313.50, -2.0%) was trading at 31.0 times of weekly average. Schneider Electric Infrastructure Ltd. (697.95, 2.8%) and CreditAccess Grameen Ltd. (1,173.80, 2.6%) were trading with volumes 19.0 and 14.4 times weekly average respectively on BSE at the time of posting this article.

BSE 500: highs, lows and moving averages

4 stocks hit their 52 week highs,

Stocks touching their year highs included - CCL Products India Ltd. (841.75, 4.6%), APL Apollo Tubes Ltd. (1,843.50, 0.3%) and Bharat Dynamics Ltd. (1,960.10, 2.7%).

24 stocks climbed above their 200 day SMA including Bayer Cropscience Ltd. (5,674, 10.6%) and ITI Ltd. (309.25, 10.0%). 15 stocks slipped below their 200 SMA including Sumitomo Chemical India Ltd. (503.20, -5.8%) and Blue Dart Express Ltd. (6,812.50, -5.2%).

Trendlyne Marketwatch
Trendlyne Marketwatch
26 May 2025
Market closes higher, Anupam Rasayan's net profit surges 44.2% YoY to Rs 44.6 crore in Q4
By Trendlyne Analysis

Nifty 50 closed at 25,001.15 (148, 0.6%), BSE Sensex closed at 82,176.45 (455.4, 0.6%) while the broader Nifty 500 closed at 22,908.30 (127.3, 0.6%). Market breadth is in the green. Of the 2,457 stocks traded today, 1,379 were in the positive territory and 1,034 were negative.

Indian indices closed in the green, led by banking and auto stocks, after Trump extended the EU trade talk deadline, easing near-term trade tensions. The Indian volatility index, Nifty VIX, rose 4.3% and closed at 18 points. Akzo Nobel declined 3.4% amid reports that JSW Paints plans to acquire a 74.8% stake for Rs 9,000 crore ($1.1 billion).

Nifty Midcap 100 & Nifty Smallcap 100 closed in the green, following the benchmark index. Nifty India Defence & Nifty Growth Sectors 15 were among the top index gainers today. According to Trendlyne’s Sector dashboard, Healthcare Equipment & Supplies emerged as the best-performing sector of the day, with a rise of 1.9%.

Asian indices closed mixed, while European indices are trading in the green except Russia’s MOEX & RTSI and UK’s FTSE 100 indices. US index futures traded higher, indicating a positive start to the trading session. Shares of Asian Apple suppliers dropped after Trump threatened a 25% tariff on imported iPhones, pushing for US manufacturing. Meanwhile, Nvidia is reportedly set to launch a lower-cost AI chip for China, priced between $6,500-$8,000, following export curbs on its higher-end models.

  • Money flow index (MFI) indicates that stocks like Honasa Consumer, Pfizer, SKF, and Bharat Electronics are in the overbought zone.

  • Healthcare Global Enterprises is falling as its net profit plunges 65.4% YoY to Rs 7.4 crore in Q4FY25 due to the absence of last year's exceptional gain. However, revenue increases 18.3% YoY to Rs 585.2 crore, driven by growth in average revenue per occupied bed (ARPOB) during the quarter. The company appears in a screener of stocks with deteriorating book value per share over the past two years.

  • Anupam Rasayan India rises sharply as its net profit surges 44.2% YoY to Rs 44.6 crore in Q4FY25, helped by inventory destocking. Revenue increases 24.7% YoY to Rs 500.2 crore, driven by growth in the pharma and polymer segments and strong performance from Tanfac Industries during the quarter. The company appears in a screener of stocks with increasing revenue every quarter for the past three quarters.

  • RateGain Travel Technologies surges as its Q4FY25 net profit grows 9.6% YoY to Rs 54.8 crore, helped by lower employee benefits and depreciation & amortisation expenses. Revenue jumps 1.9% YoY to Rs 260.7 crore, helped by new customer acquisitions. It features in a screener of stocks with rising quarterly net profit and profit margin.

  • VS Mani, ED and Global CFO of Glenmark Pharmaceuticals, projects topline growth of 10-12% and EBITDA margins at 19% for FY26. He notes that the company’s European business continues to perform well and expects steady growth in India. Mani believes critical launches in the coming quarters will support margin expansion.

  • Akzo Nobel is falling as reports suggest that JSW Paints plans to acquire a 74.8% stake for Rs 9,000 crore ($1.1 billion).

  • Motilal Oswal initiates coverage on Radico Khaitan with a 'Buy' rating and a target price of Rs 3,000. The brokerage expects strong earnings growth over the next 3–5 years, driven by opportunities in the premium and above (P&A) portfolio. It forecasts the firm’s revenue to grow at a CAGR of 16% over FY25–28.

  • Nomura downgrades Balkrishna Industries to a 'Neutral' call from 'Buy', with a lower target price of Rs 2,644 per share. The brokerage cautions that the company’s entry into the truck and car radial tyre markets faces stiff competition and expects higher upfront investments to build distribution and brand visibility. It forecasts RoE to decline by 200 bps.

  • RBI announces a record Rs 2.7 lakh crore dividend to the Centre for FY25, up 27.4% from last year’s Rs 2.1 lakh crore. Morgan Stanley believes the higher-than-expected payout supports the government’s fiscal consolidation target of 4.4% of GDP for FY26 and sustains capex momentum amid global growth and revenue uncertainties.

  • Nippon India Mutual Fund buys 19.5 lakh shares worth Rs 196 crore in Ramco Cements via a bulk deal on Friday.

  • Nibe rises sharply as it secures a Rs 150.6 crore export order from an Israeli company to manufacture and supply universal rocket launchers with a range of up to 300 km.

  • Linde India rises sharply as its net profit grows 12.3% YoY to Rs 118.4 crore in Q4FY25, driven by lower material costs, stock-in-trade purchases and inventory destocking. However, revenue decreases 6.1% YoY to Rs 591.9 crore due to lower sales from the project engineering segment during the quarter. The company appears in a screener of stocks with increasing profits every quarter for the past two quarters.

  • Rishi Raj, COO of Max Estates, projects 15–20% revenue growth for FY26 and expects booking values to reach Rs 6,000–6,500 crore. He notes that 3.6 million square feet (msf) are currently under construction, scheduled for completion in H2CY27. Max Estates also plans to launch over 7 msf projects in FY26–FY27, with a gross development value potential of Rs 14,000 crore.

  • Sun Pharmaceutical Industries announces a $25 million investment in US-based Pharmazz, raising its stake to 22.7%. The move strengthens its focus on specialty drugs in neurological and critical care segments.

  • Zydus Lifesciences receives final approval from the US FDA for its Isotretinoin capsules, used to treat acne. According to IQVIA, the drug has a market size of $115.4 million in the US as of March 2025.

  • Indigo Paints is rising as its net profit grows 6% YoY to Rs 56.9 crore in Q4FY25, helped by lower depreciation and amortisation expenses. Revenue increases marginally by 0.6% YoY to Rs 387.6 crore during the quarter. The company appears in a screener of stocks underperforming their industry price change in the quarter.

  • Eternal declines over 4% as IIFL Capital Services estimates passive outflows of $840 million. The outflows follow weight reductions by FTSE Russell and MSCI after Eternal’s Foreign Ownership Limit (FOL) was lowered from 100% to 49.5%. FTSE’s May 27 rebalancing may trigger $380 million outflows, while MSCI’s May 30 adjustment could add $460 million.

  • GE Vernova's Q4FY25 net profit surges 181.3% YoY to Rs 186.5 crore. Revenue rises 27.6% YoY to Rs 1,173.7 crore, driven by higher order inflow and exports. The firm appears in a screener of stocks where foreign institutional investors (FII) increased their stakes in Q4FY25.

  • Havells plans to increase cable manufacturing capacity by 0.25 lakh km, taking the total annual capacity to 41.4 lakh km at its Alwar facility. The company will invest Rs 340 crore in the project, which is expected to be operational by September 2026.

  • NTPC is rising as its net profit grows 23.4% YoY to Rs 7,611.2 crore in Q4FY25, helped by lower fuel costs. Revenue increases 4.6% YoY to Rs 49,833.7 crore, driven by an improvement in the generation segment during the quarter. The company appears in a screener of stocks with improving cash flow from operations over the past two years.

  • JP Morgan downgrades Ashok Leyland to a 'Neutral' rating with a higher target price of Rs 255. The brokerage anticipates sluggish growth in the commercial vehicle (CV) segment, citing continued weak truck demand and a slowdown in bus sales. As a result, it trims its FY26/27 EBITDA estimates by 4–5%. It also notes that margin drivers from the past two years could be offset by factors like a potential steel safeguard duty and a stable product mix.

  • Ashoka Buildcon rises sharply as its Q4FY25 net profit surges 73.1% YoY to Rs 432.2 crore, led by lower raw materials, construction, employee benefits, finance cost, and depreciation & amortisation expenses. However, revenue declines 12.2% YoY to Rs 2,755.4 crore due to reductions in the construction & contract segment. It appears in a screener of strong performing, under radar stocks.

  • Narayana Hrudayalaya rises sharply as its net profit grows 3.4% YoY to Rs 197.2 crore in Q4FY25. Revenue increases 15.3% YoY to Rs 1,475.4 crore, driven by an improvement in the medical and healthcare-related services segment during the quarter. The company appears in a screener of stocks where mutual funds increased their shareholding in the past quarter.

  • JSW Steel's Q4FY25 net profit grows 15.7% YoY to Rs 1,503 crore, helped by lower raw materials, inventory and mining premium & royalties expenses. However, revenue declined 3.1% YoY to Rs 45,049 crore during the quarter. It features in a screener of stocks with decreasing promoter pledges.

  • JK Cement rises sharply as its net profit surges 64% YoY to Rs 360.4 crore in Q4FY25, driven by lower purchases of traded goods, finance costs, and power & fuel expenses. Revenue increases 15.3% YoY to Rs 3,581.2 crore during the quarter. The company appears in a screener of stocks outperforming their industry price change in the quarter.

  • Nifty 50 was trading at 25,003.65 (150.5, 0.6%), BSE Sensex was trading at 81,928.95 (207.9, 0.3%) while the broader Nifty 500 was trading at 22,930.15 (149.1, 0.7%).

  • Market breadth is highly positive. Of the 2,044 stocks traded today, 1,547 were in the positive territory and 448 were negative.

Riding High:

Largecap and midcap gainers today include Linde India Ltd. (7,560.50, 7.2%), Divi's Laboratories Ltd. (6,737, 3.9%) and Solar Industries India Ltd. (15,885, 3.6%).

Downers:

Largecap and midcap losers today include Balkrishna Industries Ltd. (2,492, -6.3%), Eternal Ltd. (226.80, -4.5%) and Dalmia Bharat Ltd. (2,056.10, -4.1%).

Crowd Puller Stocks

21 stocks in BSE 500 are trading on high volumes today.

Top high volume gainers on BSE included BEML Ltd. (4,279.70, 15.1%), Gillette India Ltd. (9,389, 7.3%) and Linde India Ltd. (7,560.50, 7.2%).

Top high volume losers on BSE were Balkrishna Industries Ltd. (2,492, -6.3%), Glenmark Pharmaceuticals Ltd. (1,390.10, -2.1%) and Kansai Nerolac Paints Ltd. (254.70, -2.1%).

Gujarat Narmada Valley Fertilizers & Chemicals Ltd. (546.40, 6.4%) was trading at 16.9 times of weekly average. JK Cement Ltd. (5,213, 2.1%) and Narayana Hrudayalaya Ltd. (1,776.90, 3.0%) were trading with volumes 12.1 and 12.1 times weekly average respectively on BSE at the time of posting this article.

BSE 500: highs, lows and moving averages

15 stocks made 52 week highs, while 1 stock were underachiever and hit their 52 week lows.

Stocks touching their year highs included - City Union Bank Ltd. (196.14, 0.0%), Divi's Laboratories Ltd. (6,737, 3.9%) and EID Parry (India) Ltd. (987.10, -1.2%).

Stock making new 52 weeks lows included - Aditya Birla Fashion and Retail Ltd. (86.75, -2.0%).

20 stocks climbed above their 200 day SMA including Gillette India Ltd. (9,389, 7.3%) and IFCI Ltd. (58.45, 5.8%). 11 stocks slipped below their 200 SMA including Honasa Consumer Ltd. (315.69, -4.1%) and HBL Engineering Ltd. (555.25, -3.6%).

logo
The Baseline
23 May 2025
Five Interesting Stocks Today - May 23, 2025
By Trendlyne Analysis

1.Data Patterns:

This defence and aerospace electronics solutions provider rose 3.5% over the past week after announcing its Q4FY25 results on May 19. During the quarter, the company’s net profit grew 60.4% YoY to Rs 114 crore, and revenue increased 109%, driven by strong execution of defence contracts and a robust order backlog. 

The company receives around 57% of its revenue from the production and design segment, which grew 168% YoY to Rs 225 crore in Q4. Its key customer, the Defence Research and Development Organisation (DRDO), accounted for 55% of total revenue.

For FY25, Data Patterns' revenue grew 33% YoY and net profit rose 22%, beating Trendlyne’s Forecaster estimates. However, earnings faced pressure during Q2 and Q3 due to delayed orders and postponed deliveries. The company closed the year with an order book of Rs 730 crore, including Rs 355 crore of new orders from radar and electronic warfare systems in FY25. Radar systems contribute 60% to revenue, while electronic warfare systems account for 20%.

Over the past 18 months, the company has invested Rs 140 crore in developing fire control radars, electronic warfare receivers, and shipborne communication systems. It plans to launch these products in FY26.

Commenting on the outlook for FY26, Srinivasagopalan Rangarajan, MD, states, “We anticipate orders worth Rs 1,000–2,000 crore and 20–25% growth in revenue and profit. With the defense ministry planning to double procurement over the next four to five years and rising tensions at the border, we expect strong repeat orders and faster contract clearances for radar systems, electronic warfare suites, seekers, and avionics.”

Post results, Nirmal Bang maintains a ‘Buy’ rating on the stock and highlights the company’s strong order book in the radar and electronic warfare segment. The brokerage notes that management’s expectation of receiving emergency procurement orders from the Ministry of Defence (MoD) will support near-term growth. It expects the EBITDA margin to expand by 40 bps by FY27.

2. JSW Energy:

This power & electric utilities company rose by 2.8% after it announced its Q4FY25 and full-year results on May 15. In April, the company finalized two significant acquisitions: the 4.7 GW renewable energy platform from O2 Power for Rs 12,468 crore and KSK Mahanadi Power Co. for Rs 16,084 crore, following the National Company Law Tribunal's (NCLT) approval of its resolution plan.

Speaking about the new acquisitions, Sharad Mahendra, CEO of the company, said, “These two acquisitions are key growth drivers moving forward, both at the EBITDA and PAT levels. In an impressive turnaround, JSW Mahanadi (formerly KSK Mahanadi) achieved a 77% Plant Load Factor (PLF) within just 25 days of operation.”

The company’s net profit rose 16.1% YoY to Rs 408.1 crore in Q4FY25, helped by lower fuel costs. Revenue increased 15.7% YoY, driven by higher sales from the thermal and renewables segments. The company's Q4 net profit surpassed Trendlyne’s Forecaster estimates by 26.7%, driven by an expansion in its power portfolio. It appears in a screener of stocks outperforming their industry over the past month.

The company's positive growth in this quarter was driven by significant expansion in its operational portfolio to ~12.2GW. To achieve its Strategy 3.0 goals, the company is expanding its renewable and thermal power portfolio through organic growth and strategic acquisitions. Its key projects under development include renewables and thermal power projects, pumped hydro storage, battery storage systems and green hydrogen manufacturing. The company's management has guided for Rs 15,000-18,000 crore capex in FY26 and is targeting a total capex of Rs 1.3 lakh crore over the next 5 years.

ICICI Securities maintains a ‘Buy’ rating on JSW Energy. The brokerage notes that the company is transitioning into a renewable energy-focused player over the next 2–3 years, with integrated solar manufacturing and utility-scale storage. However, it warns that project delays and merchant price volatility could pose risks, so the brokerage has reduced its target price to Rs 612.

3. Crompton Greaves Consumer Electricals:

This household appliances player has risen 7.2% over the past week after announcing its Q4FY25 results on May 15. Crompton Greaves’ net profit grew 22.5% YoY to Rs 169.5 crore, helped by lower raw materials and finance costs, beating Trendlyne’s Forecaster estimates by 3.9%. It appears in a screener of stocks with the highest foreign institutional investor (FII) holdings.

During the quarter, revenue increased 5% YoY to Rs 2,076.6 crore, led by improvements in the electric consumer durables and Butterfly products segments. EBITDA margin was up 245bps YoY. Meanwhile, Crompton Greaves’ revenue grew 7.5% YoY for the full year to Rs 7,864 crore, and net profit increased 26.4%.

Crompton Greaves’ 2022 acquisition, Butterfly Gandhimathi Appliances, had dragged earnings for the past seven quarters but saw a revival in revenue (up 10.8% YoY) in Q4FY25. This was led by strong growth across key categories such as mixer grinders, cookers, and wet grinders. Meanwhile, the electric consumer durables segment grew 5.7% YoY.

During the final quarter of FY25, the company announced its foray into the rooftop solar business. The management highlighted that it has invested in supply chain arrangements and plans to leverage Crompton’s brand and distribution network. Commenting on this, Kaleeswaran Arunachalam, the CFO, said, “The size of the opportunity in the solar rooftop business is significant. The category is valued at Rs 20,000 crore and offers strong growth potential.” 

Analysts see strong potential for Crompton in the rooftop solar space, building on its success in solar pumps. The company introduced new products in the solar pump segment, expanded its addressable market, and recorded sales of nearly Rs 200 crore during the year.

ICICI Securities retains its Buy rating on Crompton Greaves with a lower target price of Rs 420. The brokerage expects muted Q1FY26 with unseasonal rains across India, and has trimmed its FY26–27 earnings estimates by 0.4-3.2%. 

4. DLF:

This New Delhi basedreal estate company surged 9.5% over the past week after announcing its results. The companyreported revenue growth of 29% in FY25, with net profit growth of 60%. Both revenue and net profit surpassedForecaster estimates by a wide margin.

DLF gets around 52% of its revenue from the real estate development business, another 35% from rental income and the remaining 12% from service and maintenance. DLFreported sales bookings growth of 44% YoY at Rs 21,200 crore in FY25, with over half of this coming from its super-luxury Dahilas Project in Gurugram. 

DLF’s rental business, which is mainly a 67:33 joint venture with Singapore’s sovereign wealth fund, GIC, reported a net profit growth of 21% YoY, driven by demand for workspaces and higher rent.

Analysts expect the DLF’s rental business to witness capex-led growth over FY26-30. MD of the rental business, Sriram Khattar,said, “Capex in Rentco (rental business) in FY26 and FY27 will be in the ballpark of Rs 5,000 crore.” He added, “This is a big jump from what we used to see earlier because of the pace of execution of the downtowns and the completion of Atrium Place.”

Khattar highlights that the company has adequate land to continue growing for the next several years. He believes this is a “very, very big competitive advantage” over other developers continuously scouting for land. The firm guides for booking sales similar to this year for FY26 in the range of Rs 20,000-22,000 crore.

ICICI Securitiesmaintains a ‘Buy’ rating on the stock as it expects its booking sales to surpass guidance for FY26 and grow at a CAGR of 13.5% over FY26-27. Risks to the business include a slowdown in residential demand in the NCR region and the impact of work-from-home on its rental business.

5. Sai Life Science:

This pharma company rose 4.5% on June 14 after announcing its Q4FY25 results. The company’s net profit surged 57% to Rs 88.3 crore, beating Forecaster estimates by 25.6% due to lower interest expense.

Its revenue grew 33% to Rs 589 crore, helped by higher demand for its combined contract research organization (CRO) and contract development and manufacturing organization (CDMO) services.

The revenue contribution from the CRO and CDMO segments was 37% and 63%, respectively. Siva Chittor, Director and CFO of the company said, “We expect to get to an EBITDA margin of 28% to 30% from current 25% over a 3 to 5-year period and our average growth on revenue will be between 15% and 20% for the same period, broadly in line with the 16% growth in FY25.”

During the quarter, the company expanded its manufacturing capacity by 30% and strengthened its ability to handle complex and late-stage projects. In April 2025, it launched a dedicated peptide research centre at its integrated R&D campus in Hyderabad to meet the rising demand for peptide synthesis and antibody-drug conjugates (ADCs).

Siva mentioned that Sai Life sees no immediate risk from recent US policy actions, including drug pricing reforms to lower prescription drug costs. However, CROs may face pressure as US pharma companies can cut R&D spending to offset the impact of new drug pricing rules. About 20% of Sai Life’s orders come from US pharma firms.

The company reduced its debt by Rs 720 crore during the year, meeting its IPO commitment. It invested Rs 408 crore in capital expenditure to scale manufacturing and strengthen discovery capabilities. Commenting on the capex, Siva noted that for FY26, the company plans to invest Rs 700 crore, with 60-65% towards manufacturing and the rest for R&D, including Rs 50-60 crore for new areas like peptides and ADCs.

Post results, Morgan Stanley raised its target price to Rs 911 from Rs 865, citing strong CRDMO-led growth, increased capex, and a 26% rise in contract research. It maintained its ‘overweight’ rating.

Trendlyne's analysts identify stocks that are seeing interesting price movements, analyst calls, or new developments. These are not buy recommendations.

Trendlyne Marketwatch
Trendlyne Marketwatch
23 May 2025
Market closes higher, BEML's Q4 net profit grows 12% YoY to Rs 287.6 crore
By Trendlyne Analysis

Nifty 50 closed at 24,853.15 (243.5, 1.0%), BSE Sensex closed at 81,721.08 (769.1, 1.0%) while the broader Nifty 500 closed at 22,781.05 (186.1, 0.8%). Market breadth is in the green. Of the 2,418 stocks traded today, 1,414 were on the uptick, and 959 were down.

Indian indices closed higher after rising in the morning session. The Indian volatility index, Nifty VIX, rose 0.1% and closed at 17.2 points. Honasa Consumer closed 18.8% higher as its Q4FY25 revenue increased 13% YoY to Rs 554.3 crore, beating Forecaster estimates by 9.1%, driven by double-digit growth in the e-commerce segment.

Nifty Smallcap 100 and Nifty Midcap 100 closed higher. S&P BSE Dollex 30 and Nifty FMCG Indices were among the top index gainers today. According to Trendlyne’s sector dashboard, Retailing emerged as the top-performing sector of the day, with a rise of 2%.

Asian indices closed higher, except for South Korea’s KOSPI, which closed lower. European indices are trading mixed. US index futures are trading flat, as investors stay cautious amid high US debt and a major tax cut bill. Brent crude futures are trading flat after falling 0.7% on Thursday.

  • Relative strength index (RSI) indicates that stocks like Pfizer, Bharat Electronics, Intellect Design Arena, and SKF are in the overbought zone.

  • Devyani International’s Q4FY25 revenue grows 15.4% YoY to Rs 1,225.7 crore. Net losses widen to Rs 14.7 crore from Rs 7.4 crore YoY, driven by higher employee costs and increased price of food ingredients. The firm appears in a screener of stocks where foreign institutional investors (FII) increased their stakes in Q4FY25.

  • BEML rises sharply as its Q4FY25 net profit grows 12% YoY to Rs 287.6 crore, helped by lower raw materials expenses. Revenue jumps 9.1% YoY to Rs 1,656.4 crore during the quarter. It appears in a screener of stocks with improving returns on equity (RoE) over the last two years.

  • Grasim Industries rises as its Q4FY25 net profit grows 9.2% YoY to Rs 1,495.9 crore, led by lower inventory expenses. Revenue jumps 17% YoY to Rs 44,650.7 crore, attributed to improvements in the cellulosic fibres, chemicals, building materials, and financial services segments. It features in a screener of stocks with consistently high returns over the past five years.

  • ICICI Bank expects global crude oil prices to trend lower in 2025, revising its Brent forecast to $60–70/bbl, with a potential dip to $55. It cites factors like the OPEC+ output, China’s stimulus, and Iran-related geopolitical risks.

  • Premier Explosives' Q4FY25 net profit declines 44.6% YoY to Rs 3.7 crore. Revenue decreases 14.6% YoY to Rs 74.6 crore, driven by weak growth in bulk explosives and the defence service segment. The company appears in a screener of stocks outperforming their industry price change in the quarter.

  • GMR Airports is falling as its net loss expands 96.4% YoY to Rs 237.6 crore in Q4FY25 due to higher revenue share payable to concessionaire grantors and material costs. However, revenue increases 17% YoY to Rs 2,863.3 crore, driven by higher passenger traffic during the quarter. The company appears in a screener of stocks where mutual funds increased their shareholding over the past two months.

  • Bondada Engg surges to its 10% upper circuit as it bags a Rs 9,000 crore order from the Andhra Pradesh Govt for 2000 megawatt (MW) alternating current (AC)/2600 megawatt peak (MWp) direct current (DC) solar power plants. The company will set up the plants in the Ananthapuramu and Sri Sathya Sai districts.

  • RBI Governor Sanjay Malhotra says India’s economic growth may face short-term pressures from global tariff tensions, particularly due to US trade policies under President Trump. However, he expects the economy to remain resilient, helped by strong domestic demand, robust services exports, and a low dependence on goods exports, constituting just 12% of the GDP.

  • Alembic Pharmaceuticals receives final approval from the US FDA to manufacture Amlodipine and Atorvastatin tablets used to treat high blood pressure and lower cholesterol levels. Amlodipine has a market size of $1.8 billion, and Atorvastatin tablets have a market size of $1.2 billion.

  • Indoco Remedies is rising as it receives final approval from the US FDA for its abbreviated new drug application (ANDA) for Allopurinol Tablets. The tablets, used to treat joint pain, had a market size of $1.2 billion in 2024.

  • Honasa Consumer's Q4FY25 net profit declines 18% YoY to Rs 24.9 crore due to increased advertising expenses. However, revenue increases 13% YoY to Rs 554.3 crore, driven by double-digit growth in the e-commerce segment. The firm appears in a screener of stocks where foreign institutional investors (FII) increased their stakes in Q4FY25.

  • Jindal Poly Films declines due to a fire at its subsidiary JPFL Films' Nashik plant, which started on May 21. The fire, which reportedly affected 90% of the plant’s production capacity, continues to smoulder into its fourth day, causing major operational disruptions. The blaze began in a raw material warehouse and was fueled by chemicals and plastics. No fatalities were reported.

  • Power Mech Projects rises sharply as its Q4FY25 net profit grows 38.7% YoY to Rs 117.2 crore, helped by lower inventory costs. Revenue increases 42.5% YoY to Rs 1,870 crore during the quarter. It features in a screener of stocks with strong QoQ earnings per share (EPS) growth in recent results.

  • Greenpanel Industries is falling as its net profit plunges 56.8% YoY to Rs 29.8 crore in Q4FY25 due to inventory build-up. Revenue decreases 5.5% YoY to Rs 345.3 crore, driven by lower sales from the plywood and medium density fibreboard segments during the quarter. The company appears in a screener of stocks where mutual funds increased their shareholding in the past quarter.

  • The Ramco Cements' Q4FY25 net profit plunges 78.8% YoY to Rs 27.4 crore due to higher raw materials and finance costs. Revenue declines 10.9% YoY to Rs 2,409.7 crore, caused by lower cement sales. It shows up in a screener of stocks with decreasing net cash flows.

  • Goldman Sachs maintains its 'Buy' rating on HPCL & BPCL and a 'Neutral' rating on IOC with revised target prices of Rs 475, Rs 410, and Rs 125, respectively. The brokerage believes OMCs are in a "sweet spot" due to improving macro outlook and strong refining and marketing margins. It also raises FY26–27 EBITDA estimates by an average of 26% and 5%, respectively.

  • Tata Steel expands its crude steel capacity from 3 MTPA to 8 MTPA at its Kalinganagar plant in Odisha with an investment of Rs 27,000 crore.

  • Waaree Energies falls sharply as US President Donald Trump signs a bill to eliminate funding granted under the Biden Administration, removing the 30% federal tax credit for solar rooftop installations. As of Q1FY26, exports make up 57% of Waaree Energies' order book.

  • Gujarat State Petronet is falling as its net profit plunges 53.6% YoY to Rs 220.3 crore in Q4FY25 due to higher material costs and the absence of a one-time gain from exceptional items last year. Revenue decreases 5.3% YoY to Rs 4,290.5 crore during the quarter. The company appears in a screener of stocks with declining profits every quarter for the past four quarters.

  • Lloyds Engineering Works rises over 4% as 2.7 crore shares (2.3% equity), amounting to Rs 130 crore, reportedly change hands in a block deal.

  • Trent and Bharat Electronics will replace Nestle India and IndusInd Bank in the BSE Sensex index, effective June 23. The rebalancing is expected to bring passive inflows of Rs 2,592 crore ($304 million) into Trent and Rs 2,947 crore ($354 million) into Bharat Electronics.

  • Deepak Fertilisers & Petrochemicals is falling as its Q4FY25 EBITDA margin contracts 414 bps YoY despite net profit growing 29.1% YoY to Rs 277.2 crore, driven by lower tax expenses. Revenue rises 25.9% YoY to Rs 2717 crore due to improvements in the traded and manufactured fertilisers segments. It features in a screener of top loser stocks.

  • Metro Brands is rising as its net profit beats Forecaster estimates by 13.4% despite falling 38.9% YoY to Rs 94.8 crore in Q4FY25 due to the absence of last year's tax benefits. However, revenue increases 10.3% YoY to Rs 642.8 crore, helped by strong demand for its premium products during the quarter. The company appears in a screener of stocks outperforming their industry price change in the quarter.

  • Sun Pharmaceutical Industries' Q4FY25 net profit declines 18.9% YoY to Rs 2,153.9 crore due to higher raw materials, and employee benefits expenses, and an exceptional loss of Rs 361.7 crore for legal expenses and foreign exchange losses. However, revenue grows 7.8% YoY to Rs 13,571.7 crore, driven by improvements in the formulations and specialty segments. It shows up in a screener of stocks with high promoter pledges.

  • Nifty 50 was trading at 24,618.50 (8.8, 0.0%), BSE Sensex was trading at 81,043.57 (91.6, 0.1%) while the broader Nifty 500 was trading at 22,584.85 (-10.2, 0.0%).

  • Market breadth is in the red. Of the 1,905 stocks traded today, 697 were gainers and 1,164 were losers.

Riding High:

Largecap and midcap gainers today include Bajaj Holdings & Investment Ltd. (13,748, 4.2%), Varun Beverages Ltd. (488.75, 4.1%) and Max Financial Services Ltd. (1,470, 4.0%).

Downers:

Largecap and midcap losers today include GMR Airports Ltd. (86.86, -2.4%), Container Corporation of India Ltd. (720.90, -2.3%) and Sun Pharmaceutical Industries Ltd. (1,683.60, -2.0%).

Crowd Puller Stocks

19 stocks in BSE 500 are trading on high volumes today.

Top high volume gainers on BSE included Honasa Consumer Ltd. (329.25, 19.7%), IFCI Ltd. (55.26, 10.7%) and TBO Tek Ltd. (1,320.90, 10.2%).

Top high volume loser on BSE was Sun Pharmaceutical Industries Ltd. (1,683.60, -2.0%).

The Ramco Cements Ltd. (1,006.10, 1.9%) was trading at 18.2 times of weekly average. Metro Brands Ltd. (1,210.60, 1.8%) and Clean Science & Technology Ltd. (1,433.20, 7.9%) were trading with volumes 15.8 and 12.2 times weekly average respectively on BSE at the time of posting this article.

BSE 500: highs, lows and moving averages

12 stocks hit their 52 week highs, while 1 stock were underachiever and hit their 52 week lows.

Stocks touching their year highs included - Bharat Electronics Ltd. (383.80, 0.1%), EID Parry (India) Ltd. (999.25, 1.8%) and MRF Ltd. (14,3670, 0.9%).

Stock making new 52 weeks lows included - Aditya Birla Fashion and Retail Ltd. (88.55, -1.5%).

18 stocks climbed above their 200 day SMA including Honasa Consumer Ltd. (329.25, 19.7%) and Clean Science & Technology Ltd. (1,433.20, 7.9%). 10 stocks slipped below their 200 SMA including Poly Medicure Ltd. (2,406.20, -1.7%) and Kirloskar Brothers Ltd. (1,837.70, -1.3%).

Trendlyne Marketwatch
Trendlyne Marketwatch
22 May 2025
Market closes lower, Strides Pharma's Q4 net profit surges 5x YoY to Rs 113 crore
By Trendlyne Analysis

Nifty 50 closed at 24,609.70 (-203.8, -0.8%), BSE Sensex closed at 80,951.99 (-644.6, -0.8%) while the broader Nifty 500 closed at 22,595 (-135.7, -0.6%). Market breadth is in the red. Of the 2,427 stocks traded today, 1,077 were on the uptrend, and 1,303 went down.

Indian indices closed lower after dropping in the morning session due to fears of a high US fiscal deficit. The Indian volatility index, Nifty VIX, fell 1.7% and closed at 17.3 points. Mankind Pharma closed 3.8% in the red as its Q4FY25 net profit declined 10.7% YoY to Rs 420.8 crore due to higher raw materials, inventory, employee benefits, finance, and depreciation & amortisation expenses. However, revenue grew 32.5% YoY to Rs 3,330.7 crore.

Nifty Smallcap 100 and Nifty Midcap 100 closed lower, following the benchmark index. Nifty FMCG and Nifty IT were among the worst-performing indices of the day. According to Trendlyne’s sector dashboard, Hardware Technology & Equipment emerged as the worst-performing sector of the day, with a fall of 2.4%.

European indices are trading in the red, except Portugal’s PSI index, which is trading 0.2% higher. Major Asian indices closed lower, except Indonesia’s IDX Composite and Sri Lanka’s CSE All-Share indices, which closed 0.4% and 1.2% higher. US index futures are trading mixed, indicating a cautious start to the session, ahead of the US House of Representatives’ vote on President Donald Trump’s sweeping tax and spending bill.

  • Aditya Birla Fashion & Retail sees a short buildup in its May 29 futures series, with open interest increasing by 22.8% and a put-call ratio of 0.5.

  • Strides Pharma's Q4FY25 net profit surges 5x YoY to Rs 113 crore. Revenue jumps 17% YoY to Rs 1,190 crore, driven by new product launches in the US and Africa. The firm appears in a screener of stocks where mutual funds (MF) increased their stakes over the past two months.

  • Astral surges as its Q4FY25 net profit beats Forecaster estimates by 1.7% despite falling 1.3% YoY to Rs 179.3 crore due to higher employee benefit expenses. However, revenue increases 3.5% YoY to Rs 1,681.4 crore, driven by higher sales from the plumbing and paints & adhesives segments during the quarter. The company appears in a screener of stocks with increasing profits every quarter for the past two quarters.

  • VRL Logistics' Q4FY25 net profit surges 244.7% YoY to Rs 74.2 crore. Revenue rises 5% YoY to Rs 811.5 crore, driven by higher freight rates and exits from low-margin business segments. It appears in a screener of stocks with lower PEG ratio than the industry.

  • Bajaj Auto announces plans to acquire majority control of Austrian motorcycle manufacturer KTM AG through its wholly owned subsidiary, Bajaj Auto International (BAIHBV), in a deal worth Rs 7,765 crore. The company says the acquisition supports KTM’s ongoing restructuring, ensures operational continuity, and expands Bajaj’s global footprint in the motorcycle market.

  • Gulf Oil Lubricants India's Q4FY25 net profit rises 6.9% YoY to Rs 92.2 crore, helped by inventory destocking. Revenue increases 9.6% YoY to Rs 952.7 crore, driven by growth in the personal mobility and motorcycle oils segments during the quarter. The company appears in a screener of stocks with improving cash flow from operations over the past two years.

  • Salzer Electronics secures an order worth Rs 192 crore from Bruhat Bengaluru Mahanagara Palike (BBMP) to install a centralized control and monitoring system (CCMS) for street lights and replace existing conventional streetlights in Bengaluru.

  • Star Cement is falling as its Q4FY25 net profit misses Forecaster estimates by 5%, despite growing 40.5% YoY to Rs 123.2 crore, driven by lower raw materials expenses and inventory destocking. Revenue rises 14.7% YoY to Rs 1,057.1 crore during the quarter. It shows up in a screener of stocks where promoters increased pledged shares QoQ.

  • Ashok Kumar Tyagi, Managing Director of DLF, highlights the rental run rate of around Rs 600 crore for FY25 and expects it to rise to Rs 7,500 crore by March 2026, supported by contributions from DLF and Cyber City. He reiterates DLF’s pre-sales target of Rs 22,000 crore for FY26 and emphasises the company's focus on maintaining strong free cash flows and embedded margins over volume growth.

  • HG Infra Engineering plunges as its Q4FY25 net profit declines 22.7% YoY to Rs 147 crore, owing to higher employee benefits and finance costs. Revenue falls 20.4% YoY to Rs 1,363.9 crore during the quarter. It features in a screener of stocks with declining returns on equity (RoE) over the past two years.

  • Ircon International is falling as its Q4FY25 net profit declines 14.6% YoY to Rs 210.9 crore, caused by higher raw materials and finance costs. Revenue decreases 9.7% YoY to Rs 3,515.3 crore due to reductions in the international and domestic businesses. It appears in a screener of stocks with low Piotroski scores.

  • Mankind Pharma falls sharply as its Q4FY25 net profit declines 10.7% YoY to Rs 420.8 crore due to higher raw materials, inventory, employee benefits, finance, and depreciation & amortisation expenses. However, revenue grows 32.5% YoY to Rs 3,330.7 crore, driven by improvements in the consumer healthcare, domestic and export businesses. It appears in a screener of stocks with an increasing trend in non-core income.

  • India’s Composite PMI rose to 61.2 in May, up from 59.7 in April, the fastest increase since April 2024. The increase is primarily driven by robust growth in the services sector, strong domestic and international demand, and continued investments in technology and capacity expansion.

  • Oil India is falling as its Q4FY25 net profit declines 38.8% YoY to Rs 1,310.1 crore due to higher contract, consumption of stores & spare parts, and finance costs. Revenue decreases 1.8% YoY to Rs 9,190.6 crore, caused by reductions in the crude oil, refinery products, and pipeline transportation segments. It shows up in a screener of stocks with growing costs YoY for long-term projects.

  • BSE falls sharply after reports suggest that the Securities and Exchange Board of India (SEBI) will likely approve the National Stock Exchange’s (NSE) request to introduce Tuesday as the weekly expiry day for derivatives contracts.

  • Colgate-Palmolive (India) is falling as its net profit declines 6.5% YoY to Rs 355 crore in Q4FY25 due to higher stock-in-trade purchases, employee benefit expenses, and advertising costs. Revenue decreases 1.9% YoY to Rs 1,462.5 crore during the quarter. The company appears in a screener of stocks underperforming their industry price change in the quarter.

  • Goldman Sachs reiterates its 'Sell' rating on Colgate-Palmolive (India) with a target price of Rs 2,630, citing a weak Q4 performance. The firm notes a 1.8% YoY decline in domestic revenue, falling 3% short of its estimates. It expects intense competition in the oral care segment to challenge Colgate’s margin expansion efforts, further pressured by a 100 basis point rise in advertising expenditure.

  • Va Tech Wabag's Q4FY25 net profit surges 37.4% YoY to Rs 99.5 crore. Revenue jumps 23.9% YoY to Rs 1,167.6 crore, driven by higher order inflows. The firm appears in a screener of stocks where foreign institutional investors (FII) increased their stakes in Q4FY25.

  • Garden Reach Shipbuilders is rising as it emerges as the lowest bidder for a Rs 25,000 crore order from the Ministry of Defence (MoD) to build five Next Generation Corvette (NGC) ships for the Indian Navy.

  • National Aluminium is rising as its Q4FY25 net profit surges 107.4% YoY to Rs 2,067.2 crore, helped by lower raw materials, employee benefits, and depreciation & amortisation expenses. Revenue jumps 47.2% YoY to Rs 5,393.4 crore, led by improvements in the chemicals and aluminium segments. It features in a screener of undervalued growth stocks.

  • Nomura retains a 'Neutral' rating on IndusInd Bank with a target price of Rs 700, citing concerns over accounting lapses and elevated slippages in the microfinance institution (MFI) segment. The brokerage anticipates subdued business growth and profitability. It also reduces its FY26–27 EPS estimates by 36–38%.

  • NBCC secures an order worth Rs 161.5 crore from Power Finance Corporation (PFC) for interior works at the World Trade Centre, New Delhi.

  • IndusInd Bank posts a net loss of Rs 2,328.9 crore in Q4FY25 compared to a net profit of Rs 2,349.2 crore due to higher interest, employee benefits and provisions expenses. Revenue declines 22.9% YoY to Rs 11,342.7 crore due to reductions in the treasury operations and retail banking segments. The bank's asset quality worsens as its gross and net NPAs grow 121 bps and 38 bps YoY, respectively.

  • InterGlobe Aviation's Q4FY25 net profit surges 61.9% YoY to Rs 3,067.5 crore due to lower fuel cost. Revenue increases 24.3% YoY to Rs 22,151.9 crore, driven by higher air traffic and ticket prices during the quarter. The company appears in a screener of stocks outperforming their industry price change in the quarter.

  • Oil And Natural Gas Corp's Q4FY25 net profit declines 27.6% YoY to Rs 7,322.8 crore due to higher material and exploration well costs. However, revenue increases 2.4% YoY to Rs 1,70,811.7 crore, driven by higher sales from the exploration and production segment in India during the quarter. The company appears in a screener of stocks with improving cash flow from operations over the past two years.

  • Nifty 50 was trading at 24,643.05 (-170.4, -0.7%), BSE Sensex was trading at 81,220.46 (-376.2, -0.5%) while the broader Nifty 500 was trading at 22,608.85 (-121.8, -0.5%).

  • Market breadth is in the red. Of the 1,937 stocks traded today, 819 showed gains, and 1,062 showed losses.

Riding High:

Largecap and midcap gainers today include Solar Industries India Ltd. (15,008, 5.8%), Astral Ltd. (1,442.40, 4.7%) and Berger Paints (India) Ltd. (566.40, 3.2%).

Downers:

Largecap and midcap losers today include Colgate-Palmolive (India) Ltd. (2,487.10, -6.5%), General Insurance Corporation of India (420.55, -3.6%) and Mankind Pharma Ltd. (2,439.20, -3.6%).

Volume Rockets

19 stocks in BSE 500 are trading on high volumes today.

Top high volume gainers on BSE included Tata Teleservices (Maharashtra) Ltd. (76.68, 11.0%), Fortis Healthcare Ltd. (723.80, 7.7%) and Astral Ltd. (1,442.40, 4.7%).

Top high volume losers on BSE were Aditya Birla Fashion and Retail Ltd. (89.85, -66.6%), Colgate-Palmolive (India) Ltd. (2,487.10, -6.5%) and Mankind Pharma Ltd. (2,439.20, -3.6%).

Network18 Media & Investments Ltd. (48.56, 4.0%) was trading at 6.5 times of weekly average. Relaxo Footwears Ltd. (439.65, 1.8%) and Craftsman Automation Ltd. (5,535.50, 4.5%) were trading with volumes 5.1 and 4.2 times weekly average respectively on BSE at the time of posting this article.

BSE 500: highs, lows and moving averages

8 stocks overperformed with 52 week highs, while 1 stock hit their 52 week lows.

Stocks touching their year highs included - Bharat Electronics Ltd. (383.40, 0.1%), Solar Industries India Ltd. (15,008, 5.8%) and APL Apollo Tubes Ltd. (1,829.50, 0.8%).

Stock making new 52 weeks lows included - Aditya Birla Fashion and Retail Ltd. (89.85, -66.6%).

12 stocks climbed above their 200 day SMA including Tata Teleservices (Maharashtra) Ltd. (76.68, 11.0%) and Jubilant Pharmova Ltd. (1,069.15, 7.6%). 20 stocks slipped below their 200 SMA including Mankind Pharma Ltd. (2,439.20, -3.6%) and CESC Ltd. (168.21, -2.2%).

Trendlyne Marketwatch
Trendlyne Marketwatch
21 May 2025
Market closes higher, JK Tyre's Q4 revenue jumps 1.7% YoY to Rs 3,779.8 crore
By Trendlyne Analysis

Nifty 50 closed at 24,813.45 (129.6, 0.5%), BSE Sensex closed at 81,596.63 (410.2, 0.5%) while the broader Nifty 500 closed at 22,730.65 (145.1, 0.6%). Market breadth is in the green. Of the 2,429 stocks traded today, 1,388 were on the uptick, and 985 were down.

Indian indices closed in the green after rising in the morning session. The Indian volatility index, Nifty VIX, rose 0.9% and closed at around 17.6 points. Tejas Networks closed 3.1% higher as it secured an order worth Rs 1,525.3 crore from BSNL for the supply, deployment and maintenance of 4G network at 18,685 sites.

Nifty Smallcap 100 and Nifty Midcap 100 closed in the green. Nifty India Defence and Nifty Realty closed higher. According to Trendlyne’s sector dashboard, General Industrials emerged as the best-performing sector of the day, with a rise of 2.3%.

European indices are trading flat or lower. Major Asian indices closed mixed. US index futures are trading lower, indicating a negative start to the session. TJX, Lowe’s, Medtronic, Snowflake, Target, Baidu, Zoom Communications, and XPeng are set to report their earnings later today. Brent crude futures are trading higher amid reports of a potential Israeli strike on Iranian nuclear facilities, raising supply disruption fears.

  • Money flow index (MFI) indicates that stocks like RR Kabel, Pfizer, SKF, and Ceat are in the overbought zone.

  • J Kumar Infraprojects is rising as its Q4FY25 net profit grows 12.1% YoY to Rs 114.2 crore, helped by lower administrative expenses. Revenue jumps 14.6% YoY to Rs 1,642.6 crore during the quarter. It appears in a screener of strong-performing, under radar stocks.

  • JK Tyre's Q4FY25 revenue jumps 1.7% YoY to Rs 3,779.8 crore, but net profit declines 42.6% YoY to Rs 97 crore, driven by a rise in natural rubber prices. The firm appears in a screener of stocks where mutual funds increased their stakes in Q4FY25.

  • BMW Industries rises sharply as it secures orders worth Rs 365 crore from Tata Steel to convert hot rolled coils into tubes. The contracts are valid until October 31, 2027.

  • State Bank of India's board approves its plans to raise up to $3 billion in FY26. The funds will be raised in one or more tranches through a public offering or private placement of senior unsecured notes, denominated in US dollars or other major foreign currencies.

  • Power Finance Corp is rising as its Q4FY25 net profit grows 12.3% YoY to Rs 6,316.5 crore, driven by lower corporate social responsibility expenses. Revenue jumps 20.3% YoY to Rs 29,285.5 crore during the quarter. It features in a screener of profit-making stocks with high return on capital employed (RoCE) and low PE.

  • Max Healthcare Institute's net profit grows 26.8% YoY to Rs 319 crore in Q4FY25, but misses Forecaster estimates by 21.4%. Revenue rises 34.2% YoY to Rs 1,909.7 crore, helped by strong performance in the medical and healthcare services segments. It shows up in a screener of stocks with PE higher than industry PE.

  • Whirlpool India's Q4FY25 net profit surges 53.6% YoY to Rs 119.2 crore. Revenue jumps 13.9% YoY to Rs 2,044.2 crore, driven by improvements in the refrigerator and washing machine segments. The firm appears in a screener of stocks where foreign institutional investors (FII) increased their stakes in Q4FY25.

  • Moody’s Ratings believes India is well equipped to handle the impact of US tariffs and global trade disruptions, due to its large domestic market and limited reliance on exports. The ratings agency notes that the proposed 10% universal tariffs and 30% tariffs on most Chinese exports to the US could slow global growth, potentially trimming India’s economic growth in 2025 to 6.3%, down from 6.7%.

  • United Spirits' Q4FY25 net profit jumps 74.7% YoY to Rs 421 crore, driven by lower excise duty, depreciation & amortisation, and advertisement & sales promotion expenses. Revenue grows 2.8% YoY to Rs 6,809 crore, attributed to improvements in the alcoholic beverages segment. It appears in a screener of stocks outperforming their industries in the past quarter.

  • Senores Pharmaceuticals acquires the US FDA-approved abbreviated new drug application (ANDA) for Enalapril Maleate Tablets from Wockhardt. These tablets are used to lower high blood pressure and treat heart failure. According to IQVIA, the drug had a market size of $109.2 million as of March 2025.

  • Patel Engineering secures an order worth Rs 711.2 crore from North Eastern Electric Power Corporation (NEEPCO) to construct a 240 MW hydropower project in Arunachal Pradesh under the EPC mode.

  • Oil prices are rising following reports of a potential Israeli strike on Iranian nuclear facilities, raising supply disruption fears. Brent crude climbs 1.3% to $66.3 per barrel, while WTI gains 1.4% to $62.9. The surge reflects market fears, given Iran’s role as OPEC’s third-largest producer, exporting over 1.5 million barrels per day.

  • EIH's net profit grows 13.5% YoY to Rs 252.9 crore in Q4FY25. Revenue rises 10.9% YoY to Rs 865.8 crore, led by an improvement in the hotel business. The company shows up in a screener of stocks with improving return on equity (RoE) over the past two years.

  • TCS secures a Rs 2,903.2 crore order from Bharat Sanchar Nigam Limited (BSNL) for the planning and commissioning of 4G mobile network at 18,685 sites.

  • KPR Mills falls as 1.1 crore shares (3.2% stake) worth approximately Rs 1,195.6 crore reportedly change hands in a block deal at an average price of Rs 1,107 per share. Promoters KP Ramasamy, KPD Sigamani, and P Nataraj are likely the sellers in the transaction.

  • Chetan Ahya, Chief Asia Economist at Morgan Stanley, believes India is the best-positioned economy in Asia. He cites supportive policy, a low export-to-GDP ratio, rising government spending, and strong services exports as key factors. Ahya expects above-normal rainfall and lower oil prices to keep inflation below the RBI’s 4% target midpoint.

  • Tejas Networks rises sharply as it bags an order worth Rs 1,525.3 crore from Bharat Sanchar Nigam (BSNL) for the supply, deployment and maintenance of 4G network at 18,685 sites.

  • Gland Pharma's Q4FY25 net profit declines 3.1% YoY to Rs 186.5 crore due to higher raw materials, employee benefits, and depreciation & amortisation expenses. Revenue decreases 7% YoY to Rs 1,468.9 crore, caused by reductions in the US and the rest of the world (ROW) markets. It shows up in a screener of stocks with expensive valuations according to Trendlyne valuation scores.

  • Aster DM Healthcare reports a net profit of Rs 79 crore in Q4FY25, compared to a loss of Rs 24 crore in Q4FY24 due to losses from discontinued operations. Revenue grows 2.8% YoY to Rs 1,000.3 crore, driven by an increase in patient volumes, higher average revenue per occupied bed (ARPOB), and improved average length of stay (ALOS). The company appears in a screener of stocks outperforming their industry price change in the quarter.

  • Ashutosh Raghuvanshi, Executive VC and Whole-time Director of CMS Info Systems, projects a revenue CAGR of 14–17% and anticipates a revenue contribution of ?45% from the managed services segment in the upcoming quarters. He highlights that FY25 witnessed modest growth, but the company expanded its market share across various verticals.

  • Fortis Healthcare is rising as its net profit grows 2.9% YoY to Rs 183.9 crore in Q4FY25, helped by lower inventory build-up. Revenue increases 12.4% YoY to Rs 2,007.2 crore, driven by higher sales from the healthcare and diagnostics segments during the quarter. The company appears in a screener of stocks underperforming their industry price change in the quarter.

  • Torrent Pharmaceuticals' Q4FY25 net profit grows 10.9% YoY to Rs 498 crore, helped by lower raw materials and finance costs. Revenue increases 5.9% YoY to Rs 2,941 crore, led by improvements in the US, Indian, and German markets. It appears in a screener of stocks with prices above short, medium, and long-term moving averages.

  • Ircon International is rising as it receives an order worth Rs 253.6 crore from South Western Railway to install Kavach safety systems across 778 km in the Bengaluru and Mysuru Divisions.

  • Dixon Technologies' Q4FY25 net profit surges 4.2x YoY to Rs 400.8 crore. Revenue jumps 120.4% YoY to Rs 10,303.8 crore, driven by improvements in the mobile and other electronic manufacturing services (EMS), home appliances, and lighting segments. It features in a screener of stocks with rising QoQ and trailing twelve-month (TTM) net profit margins.

  • Nifty 50 was trading at 24,723.15 (39.3, 0.2%), BSE Sensex was trading at 81,386.82 (200.4, 0.3%) while the broader Nifty 500 was trading at 22,609.30 (23.7, 0.1%).

  • Market breadth is in the red. Of the 1,979 stocks traded today, 856 showed gains, and 1,075 showed losses.

Riding High:

Largecap and midcap gainers today include GlaxoSmithKline Pharmaceuticals Ltd. (2,984.20, 7.1%), Bharat Electronics Ltd. (383, 5.3%) and Siemens Ltd. (3,290.80, 5.2%).

Downers:

Largecap and midcap losers today include Dixon Technologies (India) Ltd. (15,612, -5.8%), Max Healthcare Institute Ltd. (1,142.10, -1.9%) and IndusInd Bank Ltd. (769.95, -1.6%).

Movers and Shakers

18 stocks in BSE 500 are trading on high volumes today.

Top high volume gainers on BSE included Tata Teleservices (Maharashtra) Ltd. (69.09, 18.7%), Trident Ltd. (33.48, 13.6%) and Go Digit General Insurance Ltd. (328.60, 8.1%).

Top high volume losers on BSE were Dixon Technologies (India) Ltd. (15,612, -5.8%), KPR Mill Ltd. (1,195.05, -2.9%) and Whirlpool of India Ltd. (1,265.90, -2.3%).

Gland Pharma Ltd. (1,571.30, 4.9%) was trading at 7.0 times of weekly average. Endurance Technologies Ltd. (2,334, 5.3%) and GlaxoSmithKline Pharmaceuticals Ltd. (2,984.20, 7.1%) were trading with volumes 5.3 and 4.6 times weekly average respectively on BSE at the time of posting this article.

BSE 500: highs, lows and moving averages

5 stocks took off, crossing 52 week highs, while 1 stock tanked below their 52 week lows.

Stocks touching their year highs included - Bharat Electronics Ltd. (383, 5.3%), Ceat Ltd. (3,830.80, -0.2%) and City Union Bank Ltd. (197.57, 2.1%).

Stock making new 52 weeks lows included - Aether Industries Ltd. (740.35, 1.1%).

26 stocks climbed above their 200 day SMA including Trident Ltd. (33.48, 13.6%) and Go Digit General Insurance Ltd. (328.60, 8.1%). 15 stocks slipped below their 200 SMA including Gujarat State Fertilizer & Chemicals Ltd. (200.21, -2.6%) and Sapphire Foods India Ltd. (321.45, -2.4%).

logo
The Baseline
21 May 2025
By Omkar Chitnis

When you hear the word “Transformer,” you might picture a humming grey box behind your building. This electrical device is the backbone of energy systems that keep your lights on and appliances running.

Technologies like IoT, automation, and data analytics has fueled a bull run in the power sector. Power companies adopted these tools to increase efficiency and lower costs, leading to strong growth in electricity generation, transmission, and distribution businesses.

In the shadows of the tech boom and green revolution, transformer shares have become investors' darlings in the last five years. In this edition of Chart of the Week, we examine the five-year returns of transformer stocks and analyse the key factors driving their strong growth.

The ongoing upgradation of power lines in India and North America has created a stable growth phase for transformer makers. Visweswara Reddy, chairman of Indo Tech Transformers, said, “Unlike earlier cycles where demand peaked for 3–4 years and then dipped, the current phase is more stable and should last 12–15 years, supported by transformer replacements in India and North America.”

Due to rising energy demand, transformers are facing a similar shortage to that of Nvidia’s GPU chips

Ashish Agarwal, Head of Solar and Storage at BluePine Energy, said, “Rapid growth in railways, transmission upgrades, and renewable projects has raised transformer demand and pricing. Indian engineering, procurement, and construction (EPC) contractors executing overseas projects are boosting exports by leveraging the local supply chain.”

The global transformer market reached $76.4 billion in FY24 and is projected to reach $101.4 billion by FY29 due to increased demand from industries, data centers, and households. The Nifty Energy index has gained 193% in the past five years.

This growth in power consumption has increased demand for transmission infrastructure projects and boosted the earnings of transformer manufacturers like Transformers & Rectifiers, Voltamp Transformers, and Shilchar Technologies.

Government initiatives such as the Export Promotion Mission, National Manufacturing Mission, and Production Linked Incentive (PLI) encouraged domestic manufacturing and increased transformer exports.

Transformer makers power up capacity amid surge in orders

Rising power demand and steady government capital expenditure have pushed transformer makers to expand capacity, with large orders from industrial and utility segments driving growth. 

Transformers and Rectifiers, a heavy electrical equipment industry player, leads specialty transformer manufacturing with a 25% market share. Its share price has risen 14,468% in five years, driven by an order book that grew at a CAGR of 35.8% and increasing government projects.

As of March FY25, the order book stood at Rs 5,132 crore. Foreign institutional investors (FII) raised their stake by 6.8% YoY in Q4FY25.

The company plans to increase operational efficiency through backward integration to reduce risks from price volatility and supply disruptions. 

Management aims to achieve Rs 8,200 crore in revenue by FY28. Satyen Mamtora, MD of Transformers & Rectifiers, notes, “We are improving margins through operational efficiency and enhancing production capacity by reducing supply chain risks through backward integration. We expect FY26 revenue of Rs 3,500 crore with 15–16% profit margins.”

Voltamp Transformersholds a 15% share in the organized industrial application transformer market. Since FY20, its share price has risen 833%, and revenue has grown at a CAGR of 18.2% to Rs 2,018.9 crore in FY25, driven by diversification across data centers, oil & gas, infrastructure, and renewable energy sectors.

The company improved its net profit margin from 10% in FY20 to 16.8% in FY25, helped by higher sales of industrial transformers rated above 5 MVA and better pricing. It plans to invest Rs 200 crore to expand its manufacturing facility to produce up to 250 MVA transformers.

CG Power and Industrial Solutions derives 36% of its revenue from the power system business vertical, including the transformer business. The company increased transformer sales by implementing IoT-enabled transformers to improve efficiency, and introduced high-voltage current transformers above 800 kV. These features attracted orders from private and public companies, growing the order book at a CAGR of 42.8% in the past five years to Rs 9,909 crore.

The company plans to invest Rs 712 crore to expand transformer manufacturing capacity by 45,000 MVA, increasing total capacity to 85,000 MVA by FY28 for extra-high voltage applications. Major customers include Power Grid, Tata Power, NTPC, Larsen & Toubro, Sterling Wilson, and SPML Infra.

Ajay Jain, vice president of CG Power and Industrial Solutions, said, “We expect double-digit growth in the distribution transformer market in the next few years. We are focusing on the industrial segment, so we are investing in that segment for capacity expansion.”

Export growth lifts transformer makers' earnings

Indian transformer manufacturers are shifting their focus to international markets to increase margins and reduce dependency on local demand. Indian companies remain unaffected by tariff impacts, as most supply transformers to the Middle East and Europe.

Additionally, with support from the government’s National Manufacturing Mission, companies like Shilchar Technologies and Hitachi Energy are expanding exports of medium and high-voltage transformers to Southeast Asia, Africa, and Latin America.

Shilchar Technologies has been a standout performer, with its shares rising from the FY20 low of Rs 48 to an FY25 high of Rs 14,380, gaining 14,958%. The company shifted its product mix toward customizing transformers for renewable energy projects. This strategy improved pricing and boosted sales.

Export contribution doubled from 23% in FY20 to 50% in FY25 by entering new markets, including North America, Europe, and several countries in the South Asian market, and improved profitability driven by price gains.

On the export outlook and tariff risks, Alay J. Shah, MD of Shilchar Technologies, said, “North America accounts for about 20% of our exports, with the remaining primarily from the Middle East and North Africa. We remain confident that potential US tariffs will have minimal impact. We will monitor the situation closely as the 90-day tariff pause ends and adjust our strategy if needed.”

Apar Industries leads the power transformer oil segment with a 60% market share. Its shares have risen 2,547% in the past five years, driven by an order book that grew at a CAGR of 29% to Rs 7,163 crore.

The company ranks as the world’s third-largest transformer oil manufacturer. It exports transformer oils to 95 countries. Higher realizations from global markets have raised their international revenue share from 37% in FY20 to 44% in FY25.

Hitachi Energy manufactures 315 MVA transformers, and its shares have risen 1,805% over the past five years. The company reduced reliance on the domestic market by expanding exports of high-margin ultra-high-voltage transformers, with export contribution to order inflows rising from 18% in FY20 to 40% in FY25,  leading to the net profit margin improvement from 2.9% to 6%. 

The company’s order book grew at a CAGR of 43%, reaching Rs 19,245 crore, driven by rising orders from industries, transportation, and data centers. Strong traction drove domestic institutional investors (DII) to increase their stake by 3.3% year-on-year in Q4FY25. 

To capitalize on the growing demand, Hitachi Energy plans to invest around Rs 2,000 crore over the next 4-5 years to expand manufacturing of large power transformers, focusing on customized units for renewable projects and government work orders.

N Venu, CEO of Hitachi Energy India, notes, “Hitachi Energy India's primary focus continues to be the domestic market, supported by a strong pipeline across renewables, transmission, energy storage, and data centers. The company aims to maintain double-digit EBITDA margins in FY26.”

logo
The Baseline
21 May 2025
 What CEOs are saying about FY26 | Screener: Stocks gaining momentum after Q4 results
By Tejas MD

Financial markets have a way of surprising you. Just when everyone was talking about the Nifty 50 being stuck in a correction, the index pulled a fast one, breaking through the psychological 25,000 mark on May 15 and now hovering around 5% of its all-time highs.

A sharp 14% rebound from April lows is a reminder of how fast momentum can flip.

Not everyone is celebrating yet. As Q4 earnings come in and global trade concerns grow, especially with renewed talks about US tariffs, many CEOs are showing more caution than confidence. Volatility remains high, and most CEOs seem to be in a “wait-and-watch” mode as they look ahead to FY26.

It’s a bit like getting stuck in Bangalore traffic after a downpour—you know you’ll start moving at some point, but for now, all you can do is sit tight and hope the road clears soon.

In this Week’s Analyticks,

  • Cautious but not quiet: What CEOs are betting on for FY26
  • Screener: Stocks gaining momentum after net profit and operating profit margin improvements in Q4FY25

Uncertain times, cautious optimism: What CEOs are saying about FY26

Caution has been the dominant tone in Q4FY25 earnings calls, as global uncertainties—especially US tariff developments—cast a shadow over an otherwise strong financial performance by Indian companies. 

Despite good Q4 results, management commentary was quite guarded, even when analysts pushed management to stick their necks out. CEOs across sectors signaled the need for more “clarity” in economic developments.

We used Trendlyne’s ‘Discover’ tool to track the key concerns CEOs raised in these earnings calls.

Many leaders have pinned hopes on a sharp turnaround in the second half of FY26. Bajaj Finserv’s President, S. Sreenivasan, put it plainly, “We believe the geopolitical and external environment will be volatile in the first half of FY26, but we are very cautiously optimistic about H2 of the coming year when we should come back to growth”. 

Uncertainty and caution lead earnings call themes in Q4

Optimism hasn’t entirely vanished. CEOs highlighted strong demand trends—especially in FMCG, paints, and chemicals—as reasons for confidence. Domestic demand is proving resilient.

Most FMCG companies are upbeat about demand in FY26, thanks to softer food inflation, tax and interest rate cuts, and expectations of a good monsoon.

When asked about the outlook, Dabur CEO Mohit Malhotra said, “We are seeing green shoots in the business. So, I think food inflation is moderating. Going forward, sequential improvement is what we expect”. 

While firms like JBM Auto, L&T, and Happiest Minds raised their FY26 guidance on strong Q4 results, tech majors Infosys, HCL Tech, and Wipro cut their growth forecasts, citing global uncertainty and weak client demand. 

Tariff fog hangs over Q4 earnings calls

Top CEO talking points: Trump and tariffs

CEOs were on edge the previous quarter, but expected clarity on US tariffs by April 1st. But that clarity never came. As Q4 unfolded, Trump’s shifting stance on trade has kept the outlook murky.

Many CEOs pointed to tariffs and delays in trade agreements as a drag on decision-making, with order bookings either delayed or paused altogether. Companies like Jindal Stainless and UltraTech Cement have responded by shifting focus to domestic markets.

While explaining the dip in EBITDA per tonne, Jindal Stainless’s MD pointed to rising trade tensions as a factor. “Trade uncertainty picked up with Mr. Trump taking over. Many of our export bookings came under pressure or were put on hold, so we had to divert more volumes into the domestic market.”

CEOs are concerned about macro issues

Tech CEOs echoed these challenges. TCS CEO K. Krithivasan highlighted the inflationary impact of tariffs and the toll on IT spending: “Client IT budgets have remained flat.” CEOs are also raising slowdown and recessionary fears.

FY26: CEOs are hopeful about lower inflation and a capex push

Some CEOs sounded upbeat about FY26, pointing to easing inflation in India and early signs of a rebound in manufacturing and services. Management teams aren’t just talking up the outlook – they are backing it with spending.

FY26 key priorities: what CEOs are focusing on

Tata Steel, for instance, has announced a massive Rs 15,000 crore capital expenditure plan for FY26, which aims to drive expansion and launch new projects.

Companies like Polycab are looking at exports to fuel the next growth phase. After a slowdown in the US, Polycab is actively targeting Europe, the Middle East and Australia, with plans to ramp up revenue from these regions in the coming year.

CEOs highlighted growth pockets—especially in government contracts and pharma. For example, public sector demand has rebounded, benefiting firms like Blue Star and Netweb Technologies, after a Q3 slowdown due to elections. Blue Star’s CFO noted, “While the Industrial and BFSI sectors remained muted, government orders showed signs of revival during this quarter.”

Industry opportunities: what are CEOs bullish about?


In pharma, the spotlight was on new product launches. Cipla and Dr. Reddy’s focus on complex generics, while Alembic Pharma and Aarti Drugs are gaining momentum in API.

Meanwhile, Trump’s May 12 executive order to make US prescription drug prices the lowest globally has sparked concern. But Indian generic drug makers aren’t too worried. 

Morepen Lab’s CEO, Sushil Suri, said, “Thankfully, we’re in the generics space. These rules mainly target patented drugs, not us.” He added, “Even if President Trump wants to shake things up, the US has no alternative. They simply don’t have domestic manufacturing for generics—they rely on India.”

One thread runs through commentary by CEOs across major companies: until there’s clarity on trade policy, management teams will delay some big decisions.


Screener: Stocks gaining momentum after improvements in net profit and operating profit margin in Q4FY25

Capital markets stocks’ operating margins rise in Q4

As the Q4FY25 results season comes to a close, we look at stocks where profitability has improved YoY. This screener shows stocks with rising Trendlyne momentum scores MoM after YoY growth in net profit and operating profit margins in Q4FY25.

The screener is dominated by stocks from the finance, healthcare services, capital markets, electric utilities, and electrical equipment/products. Major stocks that show up in the screener are BSE, Reliance Power, 360 One Wam, Premier Energies, IDBI Bank, Inventurus Knowledge Solutions, and IndiaMART InterMESH.

BSE’s net profit surged 361.9% YoY during Q4FY25, with its operating profit margin expanding 32.5 percentage points to 60.5%. This capital markets company’s Trendlyne momentum score jumped MoM to 73.2. According to analysts at HDFC Securities, a 44.5% YoY reduction in regulatory fees and a Rs 109.4 crore return from provisions for the Settlement Guarantee Fund (SGF) helped improve profitability. 

Reliance Power also shows up in the screener after its net profit grew 131.5% YoY in Q4FY25, with operating profit margin expanding 20 percentage points. This electric utilities company’s Trendlyne momentum score increased MoM to 63.7 post results. Its net profit and operating margin improved due to lower fuel consumption, finance, depreciation & amortisation, and generation & administration expenses. 

You can find some popular screeners here.

Signing off this week,

The Trendlyne Team

logo
The Baseline
20 May 2025
Five stocks to buy from analysts this week - May 20, 2025
By Omkar Chitnis

1. Tata Steel:

ICICI Securities maintains its ‘Buy’ rating on this steel company and raises the target price to Rs 190, indicating an upside of 19%. Tata Steel’s EBITDA/tonne increased by Rs 1,000 QoQ in Q4FY25, up from Rs 600, due to higher selling prices and lower fixed costs.

In Q4FY25, sales volume grew 3.3% YoY to 5.6 million tonnes, driven by higher production at the Odisha facility. Tata Steel Netherlands (TSN) reported a profit of Rs 120 crore in Q4FY25, compared to a loss in the same quarter last year.

Analysts Amit Dixit and Mohit Lohia expect Tata Steel’s overall EBITDA to grow 47% to Rs 37,100 crore in FY26, driven by improvements in the UK business. They also expect profits to rise in Q1FY26 due to higher selling prices of Rs 3,000 per tonne in India and a reduction of fixed costs by Rs 1,800-2,000 per tonne.

The management aims to reduce fixed costs by Rs 11,500 crore by FY27 across India, UK, and Netherlands operations. It expects cost reductions to help its Netherlands and the UK businesses break even by Q2FY26. The company plans to invest Rs 15,000 crore in capital expenditure in FY26 and reduce debt by Rs 3,000 crore.

2. V-Guard Industries:

Anand Rathi retains its ‘Buy’ rating on this electrical appliance company with a target price of Rs 475, indicating an upside potential of 25.1%. The company’s Q4FY25 revenue rose 14.5% YoY to Rs 1,538.1 crore, driven by strong growth in the electrical and electronics segments. Net profit grew 19.6% to Rs 91.1 crore due to lower interest costs.

Analyst Prasheel Gandhi expects the company’s electronics vertical to maintain strong momentum, led by stabilizers, inverter batteries, and the solar rooftop segment. He anticipates the solar rooftop business will contribute significant revenue over the next 4–5 years.

V-Guard Industries’ battery business revenue grew in double digits YoY in FY25. The management aims to increase battery capacity with an investment of Rs 50 crore and expects a revenue potential of Rs 300–400 crore in 2.5 years. The analysts project the company’s revenue and net profit to grow at a CAGR of 14.2% and 28.8%, respectively, over FY26–27.

3. Bank of Baroda:

Sharekhan maintains a ‘Buy’ rating on this bank with a target price of Rs 260, indicating an upside of 10%. In Q4FY25, Bank of Baroda’s net profit rose 3.3% YoY to Rs 5,048 crore. Treasury gains more than doubled to Rs 1,559 crore, supporting overall profitability and pushing return on assets (RoA) to around 1.2%. The analysts said, “We believe the bank is likely to sustain RoAs at ~1.0% in FY26 led by recoveries and higher treasury gains.”

Net interest income (NII) declined 7% YoY in Q4FY25, while net interest margin (NIM) fell by 33 basis points due to lower loan yields and higher cost of funds. The analysts believe the pressure on NIMs and asset quality volatility can be managed through recoveries, treasury gains, and a better mix of loans and deposits. They also highlighted the bank’s focus on growing current account savings account (CASA) and retail term deposits, while cutting back on bulk deposits to support long-term growth.

The bank’s gross non-performing assets (NPA) fell 10 bps YoY to 2.3% in the quarter. Analysts expect NII and net profit to grow by 8.5% and 2.8% over FY26–27, aided by stable asset quality.

4. Vijaya Diagnostic Center:

Emkay reiterates its ‘Buy’ rating on this healthcare services provider chain with a target price of Rs 1,150, indicating an upside of 24.6%. Analysts Anshul Agrawal and Abin Benny believe the next 2–3 years look promising, supported by the timely commissioning of new labs in non-core geographies (such as Pune, Kolkata) and management’s guidance of over 15% sales CAGR during FY26–28, despite the asset-heavy model.

In Q4FY25, Vijaya Diagnostic’s revenue rose 12% YoY to Rs 173 crore, led by a 20% growth in the wellness segment, which contributed 15% of total revenue. However, the EBITDA margin declined by 90 bps YoY to 39.8% due to expansion-related costs. Agrawal and Benny expect margins to improve to 40.5% by FY28, backed by the management’s target to achieve breakeven within 12 months for each new lab.

The company has commissioned two new labs in Q1FY26 and plans to add three more in the next 3–4 months. Analysts believe growth will also be supported by the management’s plan to increase prices by 1–2% across various test categories during FY26.

5. Blue Jet Healthcare:

Motilal Oswal reiterates its ‘Buy’ rating on this pharma company with a target price of Rs 965, implying an upside of 21%. In Q4FY25, the company’s revenue grew 85.1% YoY to Rs 3,404 crore, driven by higher sales in pharmaceutical intermediates. Net profit rose 177% to Rs 1,101 crore, helped by new capacity additions and improved plant efficiency.

Blue Jet's capex for FY25 stood at Rs 300 crore on research and development (R&D) and expansion of production capacity. Analysts Aman Chowdhary and Sumant Kumar expect strong revenue visibility in FY26, driven by rising demand for pharma intermediates and active pharmaceutical ingredients (APIs). They project the revenue share from the pharma intermediates to rise to 25% by FY27, up from 17% in FY25, aided by expansion into new markets such as Canada, the US, and Europe.

Analysts expect strong revenue growth from the API segment in FY26, driven by new product launches and increased production capacity. They project Blue Jet’s revenue and net profit to grow at a CAGR of 27% and 25%, respectively, over FY26–27.

Note: These recommendations are from various analysts and are not recommendations by Trendlyne.

(You can find all analyst picks here)